Clinical trial · Interventional
Scalp Block in Elective Craniotomy for Tumor Dissection Trial
Regional Scalp Block With Ropivacaine 0.5% in Patients Undergoing Elective Craniotomy: a Prospective Randomized Controlled Trial
NCT03776617CI-TRIAL-00040372unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed to evaluate the effect of scalp block combined with general anesthesia on the intraoperative consumption of fentanyl and time of extubation of patients undergoing elective craniotomy. Scalp block will be applied to three groups with differences of the administered solution to the scalp and one group will be placebo group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Craniotomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| scalp block | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Group Ropivacaine
- description
- general anesthesia + scalp block with 20 ml xylocaine 1% and 20ml ropivacaine 0.5%
- interventionNames
- Procedure: scalp block
- type
- EXPERIMENTAL
- label
- Group Ropivacaine-Dexmedetomidine
- description
- general anesthesia + scalp block with 20 ml xylocaine 1%, 20ml ropivacaine 0.5% and 1mcg/kg dexmedetomidine
- interventionNames
- Procedure: scalp block
- type
- NO_INTERVENTION
- label
- Group control
- description
- general anesthesia
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with American Society of Anesthesiologists Physical status classification 1-3 * patients who are scheduled for elective craniotomy for brain tumor * patients who have provided consent for participation in the study Exclusion Criteria: * Patients who have allergy to local anesthetics and dexmedetomidine * Glasgow coma scale \<15 * tumor\>4cm * any contraindication for receiving dexmedetomidine * severe mental impairment * pregnant women * uncontrolled hypertension, arrhythmia, coagulation disorder
References
Publications (0)
Data not yet available
No reference posted for this study.